CLOSEOUT LETTER
Nutrishare Inc MARCS-CMS 543730 —
- Delivery Method:
- UPS Next Day
- Product:
- Drugs
- Recipient:
-
Recipient NameRodney J. Okamoto
-
Recipient TitleOwner and President
- Nutrishare Inc
9850 Kent Street
Elk Grove, CA 95624
United States
- Issuing Office:
- Division of Pharmaceutical Quality Operations III
United States
- (313) 393-8100
Dear Mr. Okamoto:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [Case #543730, January 16, 2018]. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Nicholas F. Lyons
Compliance Director
Division of Pharmaceutical Quality Operations III
cc: Gregory M. Killmeier
Operations Manager & Pharmacist in Charge
Nutrishare Inc.
11020 Plantside Drive
Louisville, KY 40299-6105